Andreas Halvorsen's ORIC Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 5.13 M shares of ORIC Pharmaceuticals, Inc. (ORIC) worth $55.52 M, representing 0.16% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Andreas Halvorsen has maintained a strategic position in ORIC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 2.14 M shares. Largest reduction occurred in Q1 2026, reducing 748,158 shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's ORIC Pharmaceuticals (ORIC) Holding Value Over Time
Track share changes against reported price movement
Quarterly ORIC Pharmaceuticals (ORIC) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -697,771 | Reduce 11.98% | 5.13 M | $10.83 |
| Q1 2026 | -748,158 | Reduce 11.38% | 5.82 M | $12.67 |
| Q4 2025 | -9 | Reduce 0.00% | 6.57 M | $8.18 |
| Q1 2025 | +2.14 M | Add 48.33% | 6.57 M | $5.58 |
| Q4 2024 | +431,008 | Add 10.78% | 4.43 M | $8.07 |
| Q1 2024 | +4 M | New Buy | 4 M | $13.75 |
Andreas Halvorsen's ORIC Pharmaceuticals Investment FAQs
Andreas Halvorsen first purchased ORIC Pharmaceuticals, Inc. (ORIC) in Q1 2024, acquiring 4,000,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held ORIC Pharmaceuticals, Inc. (ORIC) for 10 quarters since Q1 2024.
Andreas Halvorsen's largest addition to ORIC Pharmaceuticals, Inc. (ORIC) was in Q1 2024, adding 4,000,000 shares worth $55 M.
According to the latest 13F filing for Q2 2026, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 5,126,762 shares of ORIC Pharmaceuticals, Inc. (ORIC), valued at approximately $55.52 M.
As of the Q2 2026 filing, ORIC Pharmaceuticals, Inc. (ORIC) represents approximately 0.16% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in ORIC Pharmaceuticals, Inc. (ORIC) was 6,572,700 shares, as reported at the end of Q1 2025.